Alto Neuroscience (ANRO) Institutional Ownership $4.09 +0.09 (+2.25%) (As of 12/24/2024 04:45 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Alto Neuroscience (NYSE:ANRO)Number ofInstitutional Buyers(last 12 months)27TotalInstitutional Inflows(last 12 months)$80.17MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$5.05M Get ANRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Alto Neuroscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANRO Institutional Buying and Selling by Quarter Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Alto Neuroscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/27/2024 Franklin Resources Inc.1,220,712$13.97M0.0%+95.3%4.526% 11/19/2024 Barclays PLC29,599$339K0.0%+872.7%0.110% 11/16/2024 Geode Capital Management LLC469,988$5.38M0.0%+148.7%1.743% 11/15/2024 Barclays PLC29,599$339K0.0%+872.7%0.110% 11/15/2024 Jane Street Group LLC10,817$124K0.0%N/A0.040% 11/15/2024 Wellington Management Group LLP60,636$694K0.0%N/A0.225% Get the Latest News and Ratings for ANRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 State Street Corp236,857$2.71M0.0%+123.7%0.878% 11/15/2024 RA Capital Management L.P.2,075,154$23.74M0.3%-0.5%7.694% 11/15/2024 Philadelphia Financial Management of San Francisco LLC449,952$5.15M0.8%+1.5%1.668% 11/15/2024 Point72 Asset Management L.P.977,692$11.19M0.0%-6.9%3.625% 11/14/2024 Fred Alger Management LLC181,435$2.08M0.0%+56.1%0.673% 11/14/2024 Vestal Point Capital LP650,000$7.44M0.6%+4.8%2.411% 11/14/2024 MetLife Investment Management LLC12,783$146K0.0%N/A0.047% 11/13/2024 BNP Paribas Financial Markets4,315$49K0.0%+619.2%0.016% 11/13/2024 FMR LLC2,363,056$27.03M0.0%+1.4%8.765% 11/13/2024 The Manufacturers Life Insurance Company65,805$753K0.0%+84.5%0.244% 11/13/2024 Bowie Capital Management LLC19,484$223K0.0%-54.9%0.072% 11/12/2024 Charles Schwab Investment Management Inc.186,968$2.14M0.0%+182.5%0.694% 11/12/2024 Board of Trustees of The Leland Stanford Junior University79,740$912K0.1%-76.8%0.296% 11/8/2024 Jennison Associates LLC832,290$9.52M0.0%+80.3%3.087% 8/19/2024 Point72 Asset Management L.P.1,050,037$11.23M0.0%-6.7%3.906% 8/14/2024 Fred Alger Management LLC116,254$1.24M0.0%-1.5%0.432% 8/8/2024 Federated Hermes Inc.12,000$128K0.0%+33.3%0.045% 8/6/2024 Bowie Capital Management LLC43,186$462K0.0%N/A0.161% 8/3/2024 TD Asset Management Inc86,792$928K0.0%N/A0.323% 8/1/2024 Rhumbline Advisers10,539$113K0.0%N/A0.039% 7/26/2024 Bank of New York Mellon Corp23,557$252K0.0%N/A0.088% 5/17/2024 RA Capital Management L.P.1,385,491$21.27M0.3%N/A5.154% 5/17/2024 Artal Group S.A.350,000$5.37M0.1%N/A1.302% 5/17/2024 Zimmer Partners LP75,000$1.15M0.0%N/A0.279% 5/16/2024 AWM Investment Company Inc.299,147$4.59M0.6%N/A1.113% 5/15/2024 Price T Rowe Associates Inc. MD637,604$9.79M0.0%N/A2.372% 5/10/2024 Vanguard Group Inc.536,332$8.23M0.0%N/A1.995% 5/2/2024 Jennison Associates LLC458,599$7.04M0.0%N/A1.706% 4/30/2024 University of Texas Texas AM Investment Managment Co.22,175$340K0.1%N/A0.082% (Data available from 1/1/2016 forward) ANRO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANRO shares? During the previous two years, 29 institutional investors and hedge funds held shares of Alto Neuroscience. The most heavily invested institutionals were FMR LLC ($27.03M), RA Capital Management L.P. ($23.74M), Franklin Resources Inc. ($13.97M), Point72 Asset Management L.P. ($11.19M), Price T Rowe Associates Inc. MD ($9.79M), Jennison Associates LLC ($9.52M), and Vanguard Group Inc. ($8.23M).Learn more on ANRO's institutional investors. Which institutional investors have been buying Alto Neuroscience stock? Of the 27 institutional investors that purchased Alto Neuroscience stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($1.39M), Jennison Associates LLC ($829.21K), Price T Rowe Associates Inc. MD ($637.60K), Franklin Resources Inc. ($595.67K), Vanguard Group Inc. ($536.33K), Artal Group S.A. ($350K), and AWM Investment Company Inc. ($299.15K). How much institutional buying is happening at Alto Neuroscience? Institutional investors have bought a total of 5,735,571 shares in the last 24 months. This purchase volume represents approximately $80.17M in transactions. Which Alto Neuroscience major shareholders have been selling company stock? The following institutional investors have sold Alto Neuroscience stock in the last 24 months: Board of Trustees of The Leland Stanford Junior University ($264.27K), Point72 Asset Management L.P. ($147.31K), Bowie Capital Management LLC ($23.70K), RA Capital Management L.P. ($10.40K), and Fred Alger Management LLC ($1.76K). How much institutional selling is happening at Alto Neuroscience? Institutional investors have sold a total of 447,445 shares in the last 24 months. This volume of shares sold represents approximately $5.05M in transactions. Related Companies Organogenesis Institutional Ownership Aura Biosciences Institutional Ownership ChromaDex Institutional Ownership Korro Bio Institutional Ownership Alumis Institutional Ownership Alpha Teknova Institutional Ownership Akebia Therapeutics Institutional Ownership IGM Biosciences Institutional Ownership Cryoport Institutional Ownership GH Research Institutional Ownership This page (NYSE:ANRO) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANRO Stock Alerts